Show simple item record

dc.contributor.authorCarmona Bayonas, Alberto
dc.contributor.authorGordo Vidal, Federico 
dc.contributor.authorBeato, Carmen
dc.contributor.authorCastaño Pérez, José
dc.contributor.authorJiménez Fonseca, Paula
dc.contributor.authorVirizuela Echaburu, Juan
dc.contributor.authorGarnacho Montero, José
dc.description.abstractCancer patients comprise a vulnerable collective exposed to numerous, serious risks, beyond the cancer itself. In recent years, these individuals’ prognosis has improved substantially thanks to several advances, such as immunotherapy, targeted molecular therapies, surgical techniques, or developments in support treatment. This coincides with the prolonged survival of oncological patients hospitalized in the ICU for critical complications. Thus, the time has come to revisit intensive care support for these patients, which poses new professional as well as organizational challenges. An agreement was therefore signed in 2017 between SEOM and SEMICYUC with the aim of improving the quality of care of cancer patients with critical complications. It seeks to aid in decision-making, standardize criteria, decrease subjectivity, generate channels of communication, and delve deeper into the ethical and scientific aspects of these situations. This document sets forth the most important reasons that have led us to undertake this
dc.publisherMedicina intensivaspa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.subjectRespiratory failurespa
dc.titleIntensive care in cancer patients in the age of immunotherapy and molecular therapies: SEOM-SEMICYUC’s
dc.description.extent653 KBspa

Files in this item

SEOM-SEMICYUC-manuscript_EN dic.pdf652.3KbPDFView/Open

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 España
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 España